Quince Therapeutics (QNCX) Other financing activities (2019 - 2025)
Quince Therapeutics (QNCX) posted quarterly Other financing activities of $37000.0 for Q4 2025, down 61.46% quarter-over-quarter from $96000.0 in Q2 2025.
Quince Therapeutics (QNCX) Other financing activities (2019 - 2025) Analysis & Trends
Quince Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at $37000.0 for Q4 2025.
- In Q4 2025, Other financing activities changed N/A year-over-year to $37000.0; the TTM figure through Mar 2026 stood at $133000.0 (up 9.02% YoY), while the FY2025 annual figure was $220000.0, down 2.22% from the prior year.
- Other financing activities for Q4 2025 stood at $37000.0, down from $96000.0 in the prior quarter.
- The five-year high for Other financing activities was $4.7 million in Q3 2021, with the low at $10000.0 in Q3 2023.
- The 5-year median for Other financing activities is $72000.0 (2023), against an average of $471875.0.
- The sharpest annual moves came in 2022 and 2023: Other financing activities sank 99.7% in 2022, then soared 300.0% in 2023.
- Quince Therapeutics' Other financing activities stood at $990000.0 in 2021, then sank by 98.59% to $14000.0 in 2022, then jumped by 307.14% to $57000.0 in 2023, then slumped by 38.6% to $35000.0 in 2024, then increased by 5.71% to $37000.0 in 2025.
- Business Quant data shows QNCX's Other financing activities at $37000.0 in Q4 2025, $96000.0 in Q2 2025, and $87000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quince Therapeutics | 203.43 Mn | 203.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Jun 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 96,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 190,000.00 |
| Mar 31, 2024 | 190,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Sep 30, 2022 | 14,000.00 |